Wird geladen...
Depot haloperidol decanoate for schizophrenia
BACKGROUND: The mainstay of treatment for schizophrenia is the antipsychotic group of drugs. These are usually given orally but compliance with medication given by this route may be difficult to quantify. Problems with treatment adherence are common. The development of depot injections in the 1960s...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
1999
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045751/ https://ncbi.nlm.nih.gov/pubmed/10796438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001361 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|